150 related articles for article (PubMed ID: 37499603)
1. Integrative deep learning analysis improves colon adenocarcinoma patient stratification at risk for mortality.
Zhou J; Foroughi Pour A; Deirawan H; Daaboul F; Aung TN; Beydoun R; Ahmed FS; Chuang JH
EBioMedicine; 2023 Aug; 94():104726. PubMed ID: 37499603
[TBL] [Abstract][Full Text] [Related]
2. Spatially aware graph neural networks and cross-level molecular profile prediction in colon cancer histopathology: a retrospective multi-cohort study.
Ding K; Zhou M; Wang H; Zhang S; Metaxas DN
Lancet Digit Health; 2022 Nov; 4(11):e787-e795. PubMed ID: 36307192
[TBL] [Abstract][Full Text] [Related]
3. SAMPLER: unsupervised representations for rapid analysis of whole slide tissue images.
Mukashyaka P; Sheridan TB; Foroughi Pour A; Chuang JH
EBioMedicine; 2024 Jan; 99():104908. PubMed ID: 38101298
[TBL] [Abstract][Full Text] [Related]
4. A novel deep learning-based algorithm combining histopathological features with tissue areas to predict colorectal cancer survival from whole-slide images.
Li YJ; Chou HH; Lin PC; Shen MR; Hsieh SY
J Transl Med; 2023 Oct; 21(1):731. PubMed ID: 37848862
[TBL] [Abstract][Full Text] [Related]
5. Prediction of clinically actionable genetic alterations from colorectal cancer histopathology images using deep learning.
Jang HJ; Lee A; Kang J; Song IH; Lee SH
World J Gastroenterol; 2020 Oct; 26(40):6207-6223. PubMed ID: 33177794
[TBL] [Abstract][Full Text] [Related]
6. Computer-extracted features of nuclear morphology in hematoxylin and eosin images distinguish stage II and IV colon tumors.
Kumar N; Verma R; Chen C; Lu C; Fu P; Willis J; Madabhushi A
J Pathol; 2022 May; 257(1):17-28. PubMed ID: 35007352
[TBL] [Abstract][Full Text] [Related]
7. Deep-Hipo: Multi-scale receptive field deep learning for histopathological image analysis.
Kosaraju SC; Hao J; Koh HM; Kang M
Methods; 2020 Jul; 179():3-13. PubMed ID: 32442672
[TBL] [Abstract][Full Text] [Related]
8. Establishment of a novel prognostic signature based on an identified expression profile of integrin superfamily to predict overall survival of patients with colorectal adenocarcinoma.
Yu J; Yang K; Zheng J; Sun X; Zhao W
Gene; 2022 Jan; 808():145990. PubMed ID: 34624456
[TBL] [Abstract][Full Text] [Related]
9. Construction of a novel choline metabolism-related signature to predict prognosis, immune landscape, and chemotherapy response in colon adenocarcinoma.
Liu C; Liu D; Wang F; Liu Y; Xie J; Xie J; Xie Y
Front Immunol; 2022; 13():1038927. PubMed ID: 36451813
[TBL] [Abstract][Full Text] [Related]
10. Development of a 5-mRNAsi-related gene signature to predict the prognosis of colon adenocarcinoma.
Huang H; Lu L; Li Y; Chen X; Li M; Yang M; Huang X
PeerJ; 2023; 11():e16477. PubMed ID: 38025763
[TBL] [Abstract][Full Text] [Related]
11. The anoikis-related gene signature predicts survival accurately in colon adenocarcinoma.
Hu G; Li J; Zeng Y; Liu L; Yu Z; Qi X; Liu K; Yao H
Sci Rep; 2023 Aug; 13(1):13919. PubMed ID: 37626132
[TBL] [Abstract][Full Text] [Related]
12. Transcriptomic correlates of cell cycle checkpoints with distinct prognosis, molecular characteristics, immunological regulation, and therapeutic response in colorectal adenocarcinoma.
Wang H; Wang W; Wang Z; Li X
Front Immunol; 2023; 14():1291859. PubMed ID: 38143740
[TBL] [Abstract][Full Text] [Related]
13. A novel signature model based on mitochondrial-related genes for predicting survival of colon adenocarcinoma.
Gao H; Xing F
BMC Med Inform Decis Mak; 2022 Oct; 22(1):277. PubMed ID: 36273131
[TBL] [Abstract][Full Text] [Related]
14. Analysis of Interleukin-1 Signaling Alterations of Colon Adenocarcinoma Identified Implications for Immunotherapy.
Zhou X; Liu Y; Xiang J; Wang Y; Wang Q; Xia J; Chen Y; Bai Y
Front Immunol; 2021; 12():665002. PubMed ID: 34367132
[TBL] [Abstract][Full Text] [Related]
15. Development of somatic mutation signatures for risk stratification and prognosis in lung and colorectal adenocarcinomas.
Menor M; Zhu Y; Wang Y; Zhang J; Jiang B; Deng Y
BMC Med Genomics; 2019 Jan; 12(Suppl 1):24. PubMed ID: 30704450
[TBL] [Abstract][Full Text] [Related]
16. A potential prognostic prediction model of colon adenocarcinoma with recurrence based on prognostic lncRNA signatures.
Jin L; Li C; Liu T; Wang L
Hum Genomics; 2020 Jun; 14(1):24. PubMed ID: 32522293
[TBL] [Abstract][Full Text] [Related]
17. Glucose metabolism-based signature predicts prognosis and immunotherapy strategies for colon adenocarcinoma.
Bai Z; Yan C; Nie Y; Zeng Q; Xu L; Wang S; Chang D
J Gene Med; 2024 Jan; 26(1):e3620. PubMed ID: 37973153
[TBL] [Abstract][Full Text] [Related]
18. A pairwise immune gene model for predicting overall survival and stratifying subtypes of colon adenocarcinoma.
Jiang Z; Xu J; Zhang S; Lan H; Bao Y
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10813-10829. PubMed ID: 37316691
[TBL] [Abstract][Full Text] [Related]
19. Identification of 9 Gene Signatures by WGCNA to Predict Prognosis for Colon Adenocarcinoma.
Yang M; He H; Peng T; Lu Y; Yu J
Comput Intell Neurosci; 2022; 2022():8598046. PubMed ID: 35392038
[TBL] [Abstract][Full Text] [Related]
20. Lactate Metabolism-Associated lncRNA Pairs: A Prognostic Signature to Reveal the Immunological Landscape and Mediate Therapeutic Response in Patients With Colon Adenocarcinoma.
Xiao J; Wang X; Liu Y; Liu X; Yi J; Hu J
Front Immunol; 2022; 13():881359. PubMed ID: 35911752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
